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Although observational studies are a relatively inexpen-
sive and rapid alternative to randomized controlled trials,
critics argue that observational studies lack internal valid-
ity. For example, indication bias may limit the reliability
of outcomes data from observational studies on the cost
or safety of alternative pharmacotherapy. The workshop
will focus on the novel use of data on prior medications
to document the extent of confounding by indication.
Current research on use of anti-hypertensive and anti-
anginal medications in a Medicaid population will be
used to illustrate recommended methods for designing
and conducting observational studies. Topics covered
will include assessing and classifying the duration and
classes of prior medication history, sequencing of risk
factors and adjusting for severity of disease. The on-going
controversy over the safety of calcium channel blockers
will be examined in light of evidence on confounding by
indication. The presenters' own research will be used to
explore the evidentiary basis for current claims and
counter claims as well as the weakness of data on the key
intervening variable-exposure to the study drugs. The
workshop material is aimed at researchers with hands-on
experience using administrative databases as well as in-
dustry sponsors of outcome studies. The workshop ad-
dresses the themes of enhancing the usefulness of outcomes
research for providers and insurers by strengthening cur-
87
rent methods for identifying and eliminating systematic
biases.
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THE ROLE OF PATIENT REGISTRIES IN DISEASE
MANAGEMENT AND OUTCOMES RESEARCH
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There is growing enthusiasm for the use of health-care
claims databases representing thousands or even millions
of covered lives to assess the potential value of medical
interventions, including pharmaceuticals and disease
management programs. However, evaluations of the ef-
fectiveness and safety of such interventions conducted in
this manner may be confounded by clinical or patient dif-
ferences between treatment groups that are not captured
in readily-available databases. Patient registries designed
to meet specific research objectives can provide a more
robust source of data for outcomes research and disease
management by linking administrative databases, medical
records, patient questionnaires, death certificates, etc.
The result is comprehensive longitudinal information on
diagnosis, treatment, course of illness, outcomes, quality
of life, and costs of the diseases of interest. By seeking the
informed consent of participants the registry can also ob-
viate growing public concerns about the research use of
confidential health-care data. Workshop participants will
receive a detailed overview of the registry concept and
implementation, emphasizing its research value as well as
its potential role in support of new product development
and marketing and in the development and testing of dis-
ease management programs. Case studies of successful
registries in the fields of reproductive health, cardiovascu-
lar disease, and asthma will be used to illustrate general
principles and methods. Persons who have responsibility
for planning or conducting outcomes research or disease
management programs in the pharmaceutical industry,
hospitals, or managed care will benefit from attending
this workshop.
DAII
USING COMMUNITY PHARMACIES TO
CONDUCT OUTCOMES RESEARCH
Ungar WJ
Innovus Research Inc., Burlington, Ontario, Canada
Studies of effectiveness require that health outcomes be
measured in heterogeneous samples of patients. The
Pharmacy Medication Monitoring Program (PMMP) is
an outcomes research program which uses community
pharmacies to recruit study subjects, resulting in a broad
sample of patients treated by physicians with diverse
practice patterns. Patients are followed prospectively and
undergo repeat telephone interviews at specified inter-
vals. The purpose of this workshop is to demonstrate
how community pharmacies can be used to perform high
